Opening Soon
Opening Soon
Generalized anxiety disorder can make ordinary life feel harder to settle into. You may worry across many areas of life, even when part of you knows the worry is excessive. You may feel tense, restless, irritable, tired, or unable to quiet your mind long enough to rest.
At The Mind Grove TMS Center, we evaluate adults with generalized anxiety disorder when symptoms have not improved sufficiently in response to medications and/or therapy. Megan Bowers, MD, PhD leads that evaluation personally. She reviews your diagnosis, symptoms, treatment history, medications, safety considerations, and current care plan before making a recommendation.
TMS is considered an off-label treatment for GAD, meaning that TMS is not FDA-cleared for treatment of GAD and is not covered by insurance.
Anxiety is a normal human experience, and is even considered adaptive or advantageous in some circumstances. Generalized anxiety disorder describes a severe form of anxiety that leads to thoughts, feelings and behaviors that interfere with everyday life. Worry centers on multiple topics, and becomes persistent, difficult to control, and time consuming.
Symptoms of GAD can include insomnia (difficulty falling asleep, staying asleep, or poor sleep quality), day time fatigue, difficulty concentrating, irritability, feeling physically tense, on edge, and unable to relax. Physical symptoms can also include headaches, stomach discomfort, and body aches due to persistent muscle tension.
Generalized anxiety disorder is distinct from major depressive disorder with anxious distress, also known as anxious depression. Whereas MDD with anxious distress describes anxiety that only occurs during an episode of depression, GAD leads to symptoms of generalized anxiety even when depression is not present.
During the initial evaluation for TMS treatment, Dr. Bowers determines whether anxiety is the primary diagnosis, whether depression is also present, whether anxiety symptoms are occurring within a depressive episode, and how that should shape the treatment plan.
TMS for GAD is considered off-label, is not FDA approved, and is not covered by insurance.
Many adults with GAD begin treatment with medication, therapy, lifestyle changes, or a combination of supports. For some patients, those approaches help but do not provide enough relief. For others, symptoms return, side effects limit medication options, or the overall treatment plan needs to be reassessed.
At The Mind Grove TMS Center, each individuals’ unique history is used to guide treatment recommendations. Dr. Bowers reviews what has helped, what has not helped enough, and whether medication management, off-label TMS, or another intervention may be appropriate.
TMS is not the only option for every adult with treatment resistant GAD, and off-label care requires a clear discussion of the current evidence and its limits, safety, and the likely cost of off-label treatment.
A treatment recommendation begins with a comprehensive psychiatric evaluation. We discuss symptoms of anxiety in detail, along with medical history, current and prior mental health treatment history, and safety considerations for TMS.
Dr. Bowers also considers whether symptoms are best understood as GAD, depression with co-occurring anxiety symptoms, another anxiety disorder, or a more complex clinical picture. That distinction can affect both treatment planning and coverage by insurance.
If TMS is being considered, we discuss what is known about TMS for GAD, what remains uncertain, and what the practical treatment commitment would involve. If medication management or another clinical recommendation is a better fit, that will be discussed as well.
TMS is a noninvasive treatment that uses magnetic pulses to stimulate targeted cortical areas. It does not require anesthesia or sedation, and patients remain awake during treatment.
For generalized anxiety disorder, TMS is an off-label use. It is not FDA-cleared for GAD and is generally not covered by insurance for GAD. Research on rTMS for GAD is still developing, and published studies have been limited and varied.
For some adults, off-label TMS may still be reasonable to discuss after a careful evaluation. Dr. Bowers reviews the evidence, the limits of the evidence, your treatment history, and your clinical profile before recommending off-label TMS.
If off-label TMS is clinically appropriate, the recommended protocol depends on your diagnosis, safety profile, treatment history, schedule, and goals.
Our standard rTMS course typically includes daily treatments for four to six weeks, followed by a taper phase, for a total of 36 to 40 treatments A full course usually spans eight to ten weeks, and appointments are approximately 20 minutes.
iTBS is a form of rTMS that uses rapid theta-burst stimulation patterns. Each appointment is approximately 20 minutes, with about 3-10 minutes of stimulation.
Accelerated TMS uses iTBS or standard rTMS as its delivery method. Our Accelerated TMS protocol includes five sessions per day for six treatment days within a 14 day period, followed by 2 treatments per week, for a total of 36-40 treatments. Each appointment is approximately 20 minutes, with about 3-10 minutes of stimulation. Alternative accelerated schedules are available on a case-by-case basis.
Medication can remain part of anxiety treatment when it supports the care plan. For some patients, that may mean continuing medication during TMS. For others, the evaluation may clarify whether medication changes, off-label TMS, or another recommendation makes more sense.
If you already have a prescribing clinician, Dr. Bowers will collaborate with that provider when appropriate. If you don’t have a prescribing physician, Dr. Bowers is able to prescribe medications during your treatment course.
TMS for generalized anxiety disorder is generally not covered by insurance because it is off-label and not FDA-cleared for GAD.
Colorado Medicaid does not cover TMS.
If off-label TMS is being considered, cost and protocol-specific details should be reviewed before treatment begins.
TMS treatment takes place in our Colorado Springs office. During treatment, you remain seated and awake while the magnetic coil is positioned near the scalp. No anesthesia or sedation is required, and patients can drive themselves after treatment.
The time commitment depends on the protocol:
If TMS is recommended, Dr. Bowers monitors progress using standardized screening tools and adjusts treatment planning when clinically appropriate.
Off-label use of TMS for GAD should be approached thoughtfully . The decision to pursue TMS depends on safety screening, the current evidence and its limits, and whether TMS is a reasonable clinical fit. Cost and protocol-specific details are discussed before treatment begins.
The Mind Grove TMS Center is physician-led by Megan Bowers, MD, PhD, a dual ABPN board-certified psychiatrist in Adult Psychiatry and Child and Adolescent Psychiatry. Her background spans developmental genetics, neurobiology, and clinical psychiatry.
At The Mind Grove, that training informs how adults with GAD are evaluated, and which treatments are recommended. Dr. Bowers makes it clear when a treatment is off-label, and discusses medication and other interventions when they remain clinically useful. We use MagVenture technology for TMS treatment.
This page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. TMS is not appropriate for every patient or every condition. TMS for generalized anxiety disorder is off-label and is not FDA-cleared for GAD. A licensed clinician must evaluate symptoms, medical history, diagnosis, medications, and safety considerations before making treatment recommendations. If you are experiencing a medical or psychiatric emergency, seek emergency care immediately.
Generalized anxiety disorder is marked by persistent, difficult-to-control worry across multiple areas of life. It can affect sleep, concentration, energy, irritability, muscle tension, and daily functioning.
No. TMS is not FDA-cleared for generalized anxiety disorder. When TMS is considered for GAD, it is an off-label use.
Generally, no. TMS for GAD is generally not covered by insurance because it is off-label and not FDA-cleared for that diagnosis. Colorado Medicaid does not cover TMS.
Whereas MDD with anxious distress describes anxiety that only occurs during an episode of depression, GAD leads to symptoms of generalized anxiety even when depression is not present. The distinction matters because treatment planning, FDA-clearance language, and insurance coverage can differ depending on the primary diagnosis.
Adults with GAD whose symptoms have not improved enough with first-line treatments, such as medications and/or therapy, may be evaluated for off-label TMS. Dr. Bowers reviews diagnosis, treatment history, current medications, medical history, and safety considerations before making a recommendation. Cost and protocol-specific details should be reviewed before treatment begins.
Yes. Medication can remain part of anxiety care when it supports the treatment plan. Dr. Bowers may incorporate medication management when clinically appropriate.
National Institute of Mental Health. “Generalized Anxiety Disorder: What You Need to Know.”
Parikh, T. K., Strawn, J. R., Walkup, J. T., & Croarkin, P. E. “Repetitive Transcranial Magnetic Stimulation for Generalized Anxiety Disorder: A Systematic Literature Review and Meta-Analysis.” International Journal of Neuropsychopharmacology, 25(2), 144–146.
Conditions Treated
Clinic Full Location Text